Reach biotech founders, pharma business development teams, licensing professionals, investors, CRO and CDMO leaders, platform technology providers, research stakeholders, innovation scouts, and exhibitors connected to BIO International Convention 2026 in San Diego.
Ask for attendees only, exhibitors only, or a custom biotech-focused segmented file by company type, partnering role, geography, or title.
BIO International Convention 2026 is built around the global biotech ecosystem, bringing together biotechnology companies, pharmaceutical leaders, investors, researchers, service providers, and partnering professionals in one concentrated commercial and innovation-focused marketplace. This makes BIO 2026 especially valuable for biotech outreach that centers on partnerships, licensing, outsourcing, investment visibility, and strategic growth.
BIO is not just a scientific gathering. It is a relationship-driven biotech business environment where founders, investors, licensing teams, outsourcing partners, therapeutic innovators, and commercial stakeholders come together to build pipelines, partnerships, and long-term market opportunities.
The BIO 2026 attendees email list supports targeted outreach to decision-makers and stakeholders active across biotechnology, pharmaceutical strategy, research development, licensing, commercialization, venture activity, and innovation partnerships.
This audience is ideal for biotech partnering outreach, investor visibility, licensing conversations, CRO and CDMO prospecting, platform technology promotion, market expansion, and post-convention follow-up.
The BIO 2026 exhibitors email list supports outreach to organizations positioned across the broader life sciences services and solutions ecosystem, from development partners to technology vendors and commercialization support providers.
BIO exhibitor audiences typically include CROs, CDMOs, research services companies, biotech platform providers, manufacturing partners, AI drug discovery firms, clinical development specialists, regulatory consultants, and commercial support businesses serving biotech and pharma companies.
A combined BIO 2026 database gives you access to both the partnership-seeking side and the solution-providing side of the biotech ecosystem, helping you engage the full market around discovery, development, manufacturing, investment, licensing, and commercialization.
In biotech, the buying journey often spans founders, platform teams, investors, BD leaders, CROs, CDMOs, and strategic partners. A combined database helps you reach the network around the opportunity, not just one role type.
BIO performs best when the audience is segmented by biotech market area and innovation focus. That lets you align outreach to the right scientific, commercial, or development-stage context instead of using one broad life sciences message.
BIO is one of the strongest events for relationship-driven biotech activity. Filtering by partnering layer helps match outreach to the commercial intent behind the role, whether that is licensing, fundraising, expansion, or collaboration.
Job-title segmentation matters at BIO because influence is distributed across executives, scientific leaders, business development teams, investors, and operational partners throughout the biotech value chain.
Company-type segmentation makes biotech outreach more precise. It helps separate early innovators, enterprise biopharma, service providers, investors, and institutional stakeholders into more actionable groups.
Reach founders, early-stage platforms, and emerging biotech innovators seeking partnerships, capital, and visibility.
Connect with enterprise teams focused on partnering, scouting, pipeline expansion, and external innovation.
Target development, manufacturing, outsourcing, and support partners across the biotech delivery chain.
Engage venture, growth, and strategic investment stakeholders active in biotech and life sciences deals.
Reach translational research programs, university innovation teams, and discovery-stage collaborators.
Identify computational, AI, discovery, and enabling-technology companies within the convention ecosystem.
Connect with biotech support firms in regulatory, strategy, market access, commercialization, and operations.
Engage international biotech networks, country pavilions, market-development groups, and trade stakeholders.
BIO is a global biotech convention, so geography-based filtering supports regional targeting, international partnership programs, cross-border biotech development, and market-expansion planning.
The BIO 2026 database is structured for outreach, segmentation, spreadsheet review, partner mapping, and CRM-ready biotech marketing workflows.
| Category | Commonly Available Data Fields |
|---|---|
| Contact Identity | Full Name, First Name, Last Name |
| Professional Details | Job Title, Department, Seniority Level, Role Type |
| Organization Data | Company Name, Organization Type, Therapeutic / Service Area, Company Category |
| Direct Contact Data | Business Email Address, Phone Number if available, Website |
| Geographic Details | City, State, ZIP / Postal Code, Country, Region |
| Audience Classification | Attendee, Exhibitor, Combined Audience, Segment Type |
| Biotech Targeting | Biotech Focus, Partnering Relevance, CRO / CDMO Fit, Investor Relevance, Innovation Category |
This database is most useful for organizations that sell into biotech, partner with life sciences companies, support biopharma development, or want stronger visibility inside the innovation and partnering ecosystem.
Promote specialized development, consulting, support, and commercialization services to biotech stakeholders.
Reach biotech and pharma decision-makers evaluating outsourcing, development, and manufacturing partnerships.
Connect with companies looking for new discovery, development, data, and scientific-enablement solutions.
Identify biotech and pharma contacts relevant to alliance, pipeline, and strategic collaboration opportunities.
Gain access to the ecosystem around funding, growth, visibility, and commercial biotech relationship building.
Use BIO segments for international business development, ecosystem entry, and biotech growth planning.
Support targeted outreach, appointment-setting, and demand generation across biotech and pharma audiences.
Map company types, roles, partnering relevance, and expansion opportunities across the convention audience.
BIO 2026 contacts can support many biotech-market growth goals, from partnership development and investor outreach to pipeline visibility, vendor prospecting, and post-convention deal follow-up.
Introduce your company to biotech leaders, BD teams, and alliance stakeholders looking for collaboration opportunities.
Promote companies, technologies, and market stories to investors and funding-relevant decision-makers.
Support outreach tied to pipeline assets, technology transfer, collaboration, and strategic deal exploration.
Connect with biotech companies evaluating development, manufacturing, and outsourced support partners.
Continue convention conversations after San Diego with role-relevant biotech messaging and targeted segments.
Target by company type, therapeutic relevance, partnering role, and geography for more focused expansion.
The BIO 2026 database is prepared in a structured format designed for spreadsheet use, segmentation workflows, account mapping, partner analysis, and biotech CRM deployment.
Biotech outreach is highly relationship-driven and highly segmented. Better structure makes campaigns more precise across licensing, investment, service partnerships, scientific relevance, and company-stage targeting.
Below are common questions about the BIO International Convention 2026 biotech audience database.
Connect with biotech founders, pharma BD leaders, licensing teams, investors, CRO and CDMO stakeholders, innovation partners, and exhibitors linked to BIO International Convention 2026 in San Diego.